ES2182489T3 - Sales de calcio de antibioticos lipopeptidicos, procedimiento para su preparacion y utilizacion. - Google Patents

Sales de calcio de antibioticos lipopeptidicos, procedimiento para su preparacion y utilizacion.

Info

Publication number
ES2182489T3
ES2182489T3 ES99907547T ES99907547T ES2182489T3 ES 2182489 T3 ES2182489 T3 ES 2182489T3 ES 99907547 T ES99907547 T ES 99907547T ES 99907547 T ES99907547 T ES 99907547T ES 2182489 T3 ES2182489 T3 ES 2182489T3
Authority
ES
Spain
Prior art keywords
lipopeptidic
antibiotics
procedure
preparation
calcium salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99907547T
Other languages
English (en)
Spanish (es)
Inventor
Laszlo Vertesy
Werner Aretz
Heinrich Decker
Eberhard Ehlers
Michael Kurz
Frank Rainer Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Application granted granted Critical
Publication of ES2182489T3 publication Critical patent/ES2182489T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES99907547T 1998-02-25 1999-02-12 Sales de calcio de antibioticos lipopeptidicos, procedimiento para su preparacion y utilizacion. Expired - Lifetime ES2182489T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19807972A DE19807972A1 (de) 1998-02-25 1998-02-25 Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ES2182489T3 true ES2182489T3 (es) 2003-03-01

Family

ID=7858906

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99907547T Expired - Lifetime ES2182489T3 (es) 1998-02-25 1999-02-12 Sales de calcio de antibioticos lipopeptidicos, procedimiento para su preparacion y utilizacion.

Country Status (15)

Country Link
US (1) US6624143B1 (https=)
EP (1) EP1068223B1 (https=)
JP (1) JP4402833B2 (https=)
AR (1) AR016713A1 (https=)
AT (1) ATE223433T1 (https=)
AU (1) AU2725299A (https=)
CA (1) CA2322052C (https=)
CO (1) CO4790157A1 (https=)
DE (2) DE19807972A1 (https=)
DK (1) DK1068223T3 (https=)
ES (1) ES2182489T3 (https=)
PT (1) PT1068223E (https=)
TW (1) TW559623B (https=)
WO (1) WO1999043700A1 (https=)
ZA (1) ZA991482B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1425025A (zh) 1999-12-15 2003-06-18 卡比斯特制药公司 作为抗菌剂的新颖的脂肽
WO2001044274A1 (en) 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
MXPA02006028A (es) 1999-12-15 2004-08-23 Cubist Pharm Inc Lipopeptidos novedosos como agentes antibacterianos.
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
IL156394A0 (en) † 2000-12-18 2004-01-04 Cubist Pharm Inc Methods for preparing purified lipopeptides
JP4402463B2 (ja) 2002-01-03 2010-01-20 マイジェニックス インコーポレイテッド リポペプチド抗生物質のＤａｂ９誘導体およびそれを製造および使用する方法
CN1839150A (zh) 2003-07-17 2006-09-27 麦根克斯有限公司 脂肽抗菌衍生物组合物及其应用方法
DE102005056194A1 (de) * 2005-11-21 2007-07-12 Combinature Biopharm Ag Neue Lipopeptid Zusammensetzungen
US7795207B2 (en) 2005-11-21 2010-09-14 Harald Labischinski Lipopeptide compositions
GB0821540D0 (en) 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
BRPI0923567A2 (pt) 2008-12-22 2016-09-27 Cubist Pharm Inc agentes antibactericidas novos para o tratamento de infecções gram positivas
RU2607526C2 (ru) 2009-11-23 2017-01-10 Кьюбист Фармасьютикалз ЭлЭлСи Липопептидные композиции и родственные способы
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
CN109476704B (zh) * 2016-04-08 2022-08-16 港大科桥有限公司 抗菌环脂肽

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800162A (en) * 1987-04-01 1989-01-24 Sepracor, Inc. Method for resolution of steroisomers in multiphase and extractive membrane reactors
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5039789A (en) * 1988-04-11 1991-08-13 Eli Lilly And Company A54145 cyclic peptides
US6309440B1 (en) * 1998-08-25 2001-10-30 Thomas T. Yamashita Method and composition for promoting and controlling growth of plants
TW455591B (en) 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0994101A4 (en) * 1997-06-18 2002-05-02 Fujisawa Pharmaceutical Co NEW PREPARATION PROCESS

Also Published As

Publication number Publication date
PT1068223E (pt) 2003-01-31
JP4402833B2 (ja) 2010-01-20
ZA991482B (en) 1999-08-25
AR016713A1 (es) 2001-07-25
EP1068223A1 (de) 2001-01-17
EP1068223B1 (de) 2002-09-04
DK1068223T3 (da) 2002-12-30
US6624143B1 (en) 2003-09-23
TW559623B (en) 2003-11-01
ATE223433T1 (de) 2002-09-15
CO4790157A1 (es) 1999-05-31
JP2002528382A (ja) 2002-09-03
CA2322052A1 (en) 1999-09-02
DE19807972A1 (de) 1999-08-26
CA2322052C (en) 2009-09-29
AU2725299A (en) 1999-09-15
DE59902568D1 (de) 2002-10-10
WO1999043700A1 (de) 1999-09-02

Similar Documents

Publication Publication Date Title
ES2182489T3 (es) Sales de calcio de antibioticos lipopeptidicos, procedimiento para su preparacion y utilizacion.
GT198065892A (es) Derivados de acidos 6 b-hidroxialquilpenicilanicos como inhibidores de b-lactamasa.
ES2107762T3 (es) Utilizacion de un alquilester de glutation en una composicion cosmetica o dermatologica destinada al tratamiento por via topica del envejecimiento cutaneo.
ES2166066T3 (es) Composiciones antimicrobianas sinergicas que contienen un polimero ioneno y una sal de dodecilamina y sus metodos de utilizacion.
AR009742A1 (es) Aminoacidos modificados, medicamentos que contienen estos compuestos y procedimiento para su preparacion
FI943084A0 (fi) Uusia sulfonyyliaminopyrimidiinejä
ES2132678T3 (es) Sal de nimesulido hidrosoluble y su utilizacion para el tratamiento de las afecciones inflamatorias.
DK0840606T3 (da) Små di- og trivalente molekyler som selectininhibitorer
ATE100123T1 (de) Stabilisieren von unter abspaltung von alkoholen zu elastomeren vernetzaren organopolysiloxanmassen.
ES2184686T3 (es) Composicion que comprende un compuesto derivado de ciclohexano, compuesto y utilizacion de dicho compuesto para estructurar una composicion.
NO942135D0 (no) Smöremidler for kjedetransportbånd og deres anvendelse
ES2095421T3 (es) Composiciones termoconformables, su procedimiento de preparacion y su utilizacion para la obtencion de articulos termoconformados.
ES2107148T3 (es) Composicion tintorea, por oxidacion, de fibras queratinicas, que comprende un para-aminofenol, un meta-aminofenol y una para-fenilendiamina y/o una bis-fenilalquilendiamina.
ES2119393T3 (es) Composiciones antimicrobianas sinergisticas que contienen una acetofenona halogenada y un acido organico.
ES463409A1 (es) Procedimiento para la preparacion de nuevas fluoracil-resor-cinas sustituidas.
ES2526912T3 (es) Composición farmacéutica que contiene neurotoxina botulínica A2
ES2141256T3 (es) Composiciones antimicrobianas sinergeticas que contienen 2-(tiocianometiltio)benzotiazol y un acido organico.
ES2189766T3 (es) Pyrazolo (4,3-d)ipiridmidinas.
ES2063499T3 (es) Procedimiento para la preparacion del acido cis-beta-fenilglicidico-(2r,3r).
MX174635B (es) Composicion liquida suavizante
ES2130587T3 (es) Composiciones antimicrobianas sinergicas que contienen metilen-bis(tiocianato) y un acido organico.
ES8706692A1 (es) Un metodo para preparar nuevos derivados de cefem
AR003418A1 (es) Composición farmacéutica con actividad antiepiléptica que contiene ácido r(-)-n- (4,4-di(3-metiltien-2-il) but-3-enil)-nipecótico o sus sales y el procedimiento para su preparación.
MX9301361A (es) Derivados de carbapenema antimicrobianos y su preparacion.
DK0530639T3 (da) Heterocyclisk substituerede quinolylmethoxy-phenylacetamider som lipoxygenasehæmmere